Table 1.
Profiles of study participants with chronic incomplete SCI
| Participant | Age, yr | Sex | Cause of Spinal Cord Damage | SCI Level | AIS | Time Since SCI, yr | Baclofen |
|---|---|---|---|---|---|---|---|
| 1 | 61 | F | NT | T12 | D | N/A* | Yes |
| 2 | 52 | M | T | C5 | D | 3 | No |
| 3 | 29 | M | T | C7 | C | 6.5 | No |
| 4 | 67 | M | NT | T5 | D | 10 | Yes |
| 5 | 45 | M | T | C4 | D | 10 | Yes |
| 6 | 47 | M | T | C4 | C | 4 | Yes |
| 7 | 42 | M | T | C4 | D | 1.5 | Yes |
| 8 | 54 | M | T | C6 | D | 10 | No |
| 9 | 55 | F | NT | C6 | D | 5.5 | No |
| 10 | 39 | F | T | C4 | C | 6 | Yes |
F, female; M, male; NT, nontrauma; T, trauma; SCI, spinal cord injury; AIS, American Spinal Injury Association impairment scale.
*
Post-SCI duration cannot be determined for this participant due to her diagnosis (hereditary spastic paraparesis).